NAGASE (EUROPA) GmbH
Exhibitor at CPhI Worldwide 2019 stand 102A14, Excipients
Established in 1832, net sales of US $7 billion, Japan-based
trading house having manufacturing companies of finished dosage form (FDF) and
[Nagase Medicals Co., Ltd] A sterile FDF manufacturer, dedicated to production of injectables & liposomal dosage and specialized in oncology filed.
[Hayashibara Co., Ltd] The world largest commercial manufacturer of saccharide-base excipients (Trehalose, Maltose and Pullulan).
Specs about this supplier
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Affiliated categories:||APIs |Enzymes |Food Additive More|
Products featured at CPhI Worldwide 2019
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation